NIH Director Statement on Catalyzing the Development of Novel Alternative Methods
This report, which the ACD enthusiastically endorsed and conveyed to the agency, recommended that NIH work with the community to: Prioritize the development and use of combinatorial NAMs Establish resources, infrastructure, and collaborations to promote the use of interoperable, reliable, and well curated/high quality datasets produced from research using NAMs Promote effective dissemination and interconnection of NAM technologies Invest in comprehensive training to bolster continuous advances in development and use of NAMs Facilitate multidisciplinary teams with expertise across technologies and the lifecy...
Source: NIH Extramural Nexus - February 9, 2024 Category: Research Authors: Mike Lauer Tags: blog Open Mike Alternatives to Animals Animal Welfare rigor Source Type: funding

Notice of Change to Award Budget for PAR-23-032, Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed
Notice NOT-AR-23-021 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2023 Category: Research Source Type: funding

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Funding Opportunity PAR-24-035 from the NIH Guide for Grants and Contracts. Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2023 Category: Research Source Type: funding

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-036 from the NIH Guide for Grants and Contracts. Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 6, 2023 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplement for Accelerating Research in Understudied Skin Types
Notice NOT-AR-24-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 31, 2023 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Accelerating Research in Understudied Skin Types
Notice NOT-AR-24-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 31, 2023 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplements to NIAMS-funded T32 Training Grants to Better Incorporate Pain Related Research in Rheumatic, Skin and Musculoskeletal Diseases Workforce Development
Notice NOT-AR-23-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 3, 2023 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions to Add or Expand Research and Administrative Supplements on Cutting Edge Pain Research in Rheumatic, Skin, and Musculoskeletal Disease.
Notice NOT-AR-23-015 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 3, 2023 Category: Research Source Type: funding

Notice of Correction to RFA-AR-24-001, "NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)"
Notice NOT-AR-23-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 20, 2023 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
Notice NOT-AR-23-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 29, 2022 Category: Research Source Type: funding

NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
Funding Opportunity RFA-AR-24-001 from the NIH Guide for Grants and Contracts. NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 27, 2022 Category: Research Source Type: funding

Notice to Extend the Response Date for NOT-AR-22-023 "Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029"
Notice NOT-AR-23-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2022 Category: Research Source Type: funding

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Funding Opportunity PAR-23-032 from the NIH Guide for Grants and Contracts. Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2022 Category: Research Source Type: funding

Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029
Notice NOT-AR-22-023 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2022 Category: Research Source Type: funding

Notice of Clarification for PAS-21-245 Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Notice NOT-AR-22-021 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2022 Category: Research Source Type: funding